# RILPL1

## Overview
RILPL1 (Rab interacting lysosomal protein like 1) is a gene that encodes a protein involved in critical cellular processes, particularly in lysosomal dynamics and centrosomal function. The protein encoded by RILPL1 is categorized as a lysosomal-associated protein that interacts with Rab GTPases, such as Rab8 and Rab10, and is implicated in the regulation of lysosomal positioning and tubule dynamics. It plays a significant role in cellular homeostasis by facilitating retrograde transport and tubule retraction along microtubules, processes essential for autophagy and cellular waste degradation (BonetPonce2024Opposing). Additionally, RILPL1 localizes to the centrosome, suggesting a role in ciliogenesis and centrosomal cohesion, which are vital for maintaining cellular structure and function (Ordóñez2021LRRK2). The protein's interactions with phosphorylated Rab proteins and its recruitment to LRRK2-positive lysosomes underscore its importance in neuroprotective pathways, particularly in the context of Parkinson's disease (Taylor2020Advances; Lara2019RAB8).

## Function
RILPL1 (Rab interacting lysosomal protein like 1) is involved in several critical cellular processes, primarily through its interactions with Rab GTPases, such as Rab8 and Rab10. In healthy human cells, RILPL1 plays a significant role in lysosomal dynamics and positioning. It is recruited to lysosomes by LRRK2, a kinase associated with Parkinson's disease, where it interacts with the dynein/dynactin complex to facilitate retrograde transport and tubule retraction along microtubules (BonetPonce2024Opposing). This interaction is crucial for maintaining lysosomal positioning and function, impacting processes like autophagy and cellular waste degradation, which are essential for cellular homeostasis.

RILPL1 also localizes to the centrosome, particularly at the subdistal appendages of the mother centriole, where it interacts with phosphorylated Rab proteins. This localization suggests a role in centrosomal function and organization, potentially affecting ciliogenesis and centrosomal cohesion (Ordóñez2021LRRK2). The protein's involvement in these processes highlights its importance in maintaining cellular structure and function, with implications for neuroprotection and cellular signaling pathways (Taylor2020Advances).

## Clinical Significance
RILPL1 is implicated in several neurological disorders, particularly through its interactions with LRRK2, a kinase associated with Parkinson's disease (PD). Mutations in LRRK2 lead to increased kinase activity, resulting in the phosphorylation of Rab GTPases such as Rab8A and Rab10. These phosphorylated Rabs interact with RILPL1, causing defects in ciliogenesis and centrosome cohesion, which are cellular processes crucial for neuronal function (Alexander2023Targeting; Lara2019RAB8). These interactions are significant in the context of PD, as they affect the ability of neurons to respond to Sonic hedgehog signaling, a pathway important for neuroprotection (Dhekne2018A).

RILPL1 is also involved in lysosomal dynamics, where it interacts with LRRK2 to influence lysosomal membrane damage responses. This interaction is relevant to conditions involving lysosomal dysfunction, which can contribute to neurodegenerative diseases (BonetPonce2024Opposing). The role of RILPL1 in these processes suggests that alterations in its expression or function could exacerbate the pathological mechanisms of PD and potentially other neurodegenerative disorders (BonetPonce2024Opposing; Dhekne2018A).

## Interactions
RILPL1 interacts with phosphorylated forms of Rab GTPases, specifically RAB8 and RAB10, which are crucial for its role in cellular processes such as centrosomal cohesion and ciliogenesis. These interactions are mediated by the binding of RILPL1 to the phosphorylated switch II region of these Rab proteins, a process that is dependent on LRRK2 kinase activity (Alexander2023Targeting; Lara2019RAB8). RILPL1 is recruited to LRRK2-positive lysosomes through its interaction with phosphorylated RAB10, and this recruitment is essential for lysosomal positioning and tubulation (BonetPonce2024Opposing).

RILPL1 also interacts with the dynactin subunit p150 Glued, acting as a dynein adaptor protein. This interaction facilitates the recruitment of dynactin to damaged lysosomes and influences the movement and positioning of LRRK2-positive lysosomes along microtubules (BonetPonce2024Opposing). Additionally, RILPL1's interaction with JIP4 on lysosomal tubules suggests a role in regulating tubule dynamics, where RILPL1 triggers tubule retraction while JIP4 promotes elongation (BonetPonce2024Opposing). These interactions highlight RILPL1's involvement in the dynamic regulation of lysosomal membrane reformation and its potential impact on neuroprotective circuits in the brain, particularly in the context of Parkinson's disease models with LRRK2 mutations (Lara2019RAB8).


## References


1. (Alexander2023Targeting) Targeting Rab-RILPL Interactions as a Strategy to Downregulate Pathogenic LRRK2 in Parkinson’s Disease. This article has 0 citations.

[2. (Dhekne2018A) Herschel S Dhekne, Izumi Yanatori, Rachel C Gomez, Francesca Tonelli, Federico Diez, Birgitt Schüle, Martin Steger, Dario R Alessi, and Suzanne R Pfeffer. A pathway for parkinson’s disease lrrk2 kinase to block primary cilia and sonic hedgehog signaling in the brain. eLife, November 2018. URL: http://dx.doi.org/10.7554/elife.40202, doi:10.7554/elife.40202. This article has 187 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.40202)

[3. (Lara2019RAB8) Antonio Jesús Lara Ordónez, Belén Fernández, Elena Fdez, María Romo-Lozano, Jesús Madero-Pérez, Evy Lobbestael, Veerle Baekelandt, Ana Aiastui, Adolfo López de Munaín, Heather L Melrose, Laura Civiero, and Sabine Hilfiker. Rab8, rab10 and rilpl1 contribute to both lrrk2 kinase–mediated centrosomal cohesion and ciliogenesis deficits. Human Molecular Genetics, 28(21):3552–3568, August 2019. URL: http://dx.doi.org/10.1093/hmg/ddz201, doi:10.1093/hmg/ddz201. This article has 79 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddz201)

4. (BonetPonce2024Opposing) Opposing actions of JIP4 and RILPL1 provide antagonistic motor force to dynamically regulate membrane reformation during lysosomal tubulation/sorting driven by LRRK2. This article has 1 citations.

[5. (Taylor2020Advances) Matthew Taylor and Dario R. Alessi. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and parkinson’s disease. Current Opinion in Cell Biology, 63:102–113, April 2020. URL: http://dx.doi.org/10.1016/j.ceb.2020.01.001, doi:10.1016/j.ceb.2020.01.001. This article has 99 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ceb.2020.01.001)

6. (Ordóñez2021LRRK2) LRRK2 causes centrosomal deficits via phosphorylated Rab10 and RILPL1 at centriolar subdistal appendages. This article has 2 citations.